Exhibit 23.2
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-3 of VistaGen Therapeutics, Inc. of our report dated June 25, 2019 (which report expresses an unqualified opinion and includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern), relating to the consolidated financial statements of VistaGen Therapeutics, Inc. appearing in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2019.
 
We also consent to the reference to us under the caption “Experts” in the Prospectus.
 
/s/ OUM & CO. LLP
 
San Francisco, California
May 1, 2020